Skip to main content
logo
Danaher Corporation (DHR)
NYSE: DHR · Real-Time Price · USD
167.04
+3.18 (1.94%)
At close: May 19, 2026, 4:00 PM EDT
167.90
+0.86 (0.52%)
Pre-market: May 20, 2026, 8:06 AM EDT

Danaher Operating Metrics

Period EndingMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018
Recurring Revenue
20.34B20.13B19.91B19.67B19.39B19.37B17.04B17.44B
Recurring Revenue Growth
4.93%3.93%16.85%12.76%7.16%3.66%-11.11%-11.95%

Revenue by Segment

Period EndingMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Diagnostics
9.91B9.94B9.86B9.76B9.71B9.79B9.87B9.76B
Diagnostics Growth
2.06%1.57%-0.08%0.01%-0.20%2.19%0.41%-4.82%
Biotechnology
7.48B7.29B7.13B6.98B6.85B6.76B6.65B6.66B
Biotechnology Growth
9.22%7.90%7.22%4.86%0.22%-5.76%-12.93%11.52%
Life Sciences
7.39B7.33B7.28B7.27B7.26B7.33B7.23B7.15B
Life Sciences Growth
1.75%0.07%0.75%1.68%1.21%2.63%0.98%-22.50%
Environmental and Applied Solutions
-------1.25B
Environmental and Applied Solutions Growth
--------74.54%

Operating Income by Segment

Period EndingMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Diagnostics
2.61B2.65B2.56B2.51B2.51B2.63B2.77B2.69B
Diagnostics Growth
3.70%0.95%-7.44%-6.69%-1.80%9.10%5.25%-5.61%
Biotechnology
1.96B1.86B1.83B1.87B1.74B1.63B1.53B1.56B
Biotechnology Growth
12.41%14.71%19.50%19.87%6.29%-14.88%-29.87%-11.81%
Life Sciences
544.00M520.00M560.00M373.00M845.00M879.00M738.00M1.02B
Life Sciences Growth
-35.62%-40.84%-24.12%-63.29%-24.76%-27.30%-45.97%-51.57%
Environmental
-------286.00M
Environmental Growth
--------76.03%
Other
-347.00M-344.00M-340.00M-337.00M-334.00M-326.00M-323.00M-358.00M

Revenue by Geography

Period EndingMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
North America
10.25B10.36B10.45B10.25B10.25B10.30B10.11B10.71B--
North America Growth
0.07%0.59%3.39%-4.30%-8.55%-11.20%-20.23%-18.75%--
High Growth Markets
7.11B7.02B6.88B6.87B6.87B6.87B6.88B7.23B--
High Growth Markets Growth
3.48%2.21%-0.04%-5.03%-11.17%-17.03%-21.28%-19.12%--
Western Europe
6.16B5.94B5.86B5.66B5.48B5.46B5.31B5.58B--
Western Europe Growth
12.45%8.81%10.41%1.53%-8.17%-14.04%-21.16%-18.06%--
Other Developed Markets
1.26B1.25B1.25B1.23B1.23B1.25B1.27B1.30B--
Other Developed Markets Growth
2.44%-0.08%-1.51%-5.03%-7.68%-9.21%-10.53%-8.99%--

Operating Expense Breakdown

Period EndingMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019
Selling, General, and Administrative
8.24B8.24B8.23B8.30B7.81B7.76B7.77B7.86B
Selling, General, and Administrative Growth
5.47%6.13%5.93%5.66%-4.53%-8.94%-10.43%-9.49%
Research and Development
1.61B1.60B1.60B1.61B1.60B1.58B1.55B1.58B
Research and Development Growth
0.69%0.88%3.42%1.52%-0.93%-5.21%-9.78%-7.97%
Source: Business metrics provided by TipRanks and sourced from official company press releases and documents.